The introduction of troglitazone, a potent glucose-lowering agent, marked a significant chapter in the management of type 2 diabetes. However, its removal from the market due to severe hepatotoxicity spurred extensive https://blanchebtxv845564.blog5.net/91707383/troglityzone-and-related-glitazones-a-contrasting-overview